A Study on Weight Loss Cause as per the Side Effect of Liraglutide

2Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose. Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reduction and its maintenance in real-world practice. Methods. Endocrinologists conducted a retrospective chart review of data from two tertiary university hospitals. All patients who had been prescribed liraglutide at least once between January 2014 and December 2019 were included. For an average of 3 and 6 months, weight changes due to the presence or absence of SE and discontinuation (MAIN or STOP) of liraglutide were checked. Results. Only 40.8% (64/157) of the patients remained on liraglutide for 6 months; 14.7% (23/157) maintained the drug despite SEs (MAIN_SE(+)), and 40.1% (63/157) discontinued the drug despite not having SEs (STOP_SE(-)). At 3 months, there was -5.9±0.6%, -7.9±0.9%, -4.5±0.5%, and -3.4±0.6% weight reduction in the MAIN_SE(-), MAIN_SE(+), STOP_SE(-), and STOP_SE(+) groups, respectively (all p<0.001 compared to the baseline). However, there were no significant differences in the weight loss between the MAIN (p=0.062) and STOP (p=0.204) groups. At 6 months, the weight reduction was -2.0±0.5% (p<0.001) in MAIN_SE(-), -2.2±0.7% (p<0.005) in MAIN_SE(+), -1.7±0.7% (p<0.01) in STOP_SE(-), and -2.0±0.6% (p=0.01) in STOP_SE(+), compared to baseline. SEs also caused no significant differences in weight loss between the MAIN (p=0.787) and STOP (p=0.694) groups. Conclusions. Our study confirmed that the side effects of liraglutide did not affect weight reduction. Moreover, in the real world, the continuous rate of liraglutide use is not high, and the weight gradually increases after 3 months. Therefore, in addition to the side effects of liraglutide, the medical staff should consider various factors that affect drug adherence, consider ways to increase compliance, and continue to ensure management so that patients can maintain their weight.

References Powered by Scopus

Association of pharmacological treatments for obesity withweight loss and adverse events a systematic review and meta-analysis

605Citations
N/AReaders
Get full text

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

602Citations
N/AReaders
Get full text

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

595Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice

13Citations
N/AReaders
Get full text

Assessment of Jordanian Pharmacists’ Knowledge and Awareness of Liraglutide Injection and their Practice in Counseling Obesity Patients

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yu, J., Lee, J., Lee, S. H., Cho, J. H., & Kim, H. S. (2022). A Study on Weight Loss Cause as per the Side Effect of Liraglutide. Cardiovascular Therapeutics, 2022. https://doi.org/10.1155/2022/5201684

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Lecturer / Post doc 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

43%

Biochemistry, Genetics and Molecular Bi... 2

29%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Nursing and Health Professions 1

14%

Save time finding and organizing research with Mendeley

Sign up for free